These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 20050899
1. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, Bellelli G, Padovani A. Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899 [Abstract] [Full Text] [Related]
2. Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients. Maiovis P, Ioannidis P, Gerasimou G, Gotzamani-Psarrakou A, Karacostas D. J Neuropsychiatry Clin Neurosci; 2017 May; 29(1):26-30. PubMed ID: 27417072 [Abstract] [Full Text] [Related]
10. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline]. Vanderzeypen F, Bier JC, Genevrois C, Mendlewicz J, Lotstra F. Encephale; 2003 Dec; 29(2):172-80. PubMed ID: 14567169 [Abstract] [Full Text] [Related]
11. Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR. Kim EJ, Kim BC, Kim SJ, Jung DS, Sin JS, Yoon YJ, Chin J, Lee KH, Na DL. Dement Geriatr Cogn Disord; 2012 Dec; 34(5-6):300-6. PubMed ID: 23208196 [Abstract] [Full Text] [Related]
12. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study. Paolillo EW, Casaletto KB, Clark AL, Taylor JC, Heuer HW, Wise AB, Dhanam S, Sanderson-Cimino M, Saloner R, Kramer JH, Kornak J, Kremers W, Forsberg L, Appleby B, Bayram E, Bozoki A, Brushaber D, Darby RR, Day GS, Dickerson BC, Domoto-Reilly K, Elahi F, Fields JA, Ghoshal N, Graff-Radford N, G H Hall M, Honig LS, Huey ED, Lapid MI, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Mester C, Miyagawa T, Naasan G, Pascual B, Pressman P, Ramos EM, Rankin KP, Rexach J, Rojas JC, VandeVrede L, Wong B, Wszolek ZK, Boeve BF, Rosen HJ, Boxer AL, Staffaroni AM, ALLFTD Consortiumsee Acknowledgements, San Francisco, CA, United States.. JMIR Aging; 2024 Jun 26; 7():e52831. PubMed ID: 38922667 [Abstract] [Full Text] [Related]
13. Brain perfusion patterns in familial frontotemporal lobar degeneration. Seelaar H, Papma JM, Garraux G, de Koning I, Reijs AE, Valkema R, Rozemuller AJ, Salmon E, van Swieten JC. Neurology; 2011 Jul 26; 77(4):384-92. PubMed ID: 21753175 [Abstract] [Full Text] [Related]
14. Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates. Borroni B, Grassi M, Agosti C, Premi E, Alberici A, Paghera B, Lucchini S, Di Luca M, Perani D, Padovani A. Rejuvenation Res; 2009 Feb 26; 12(1):33-44. PubMed ID: 19236162 [Abstract] [Full Text] [Related]
15. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J. Neurol Res; 2010 Mar 26; 32(2):157-65. PubMed ID: 20158954 [Abstract] [Full Text] [Related]
16. Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, Heuer HW, Knopman D, Kornak J, Boxer A, Rosen HJ, Boeve BF, Appleby B, Bordelon Y, Bove J, Brannelly P, Caso C, Coppola G, Dever R, Dheel C, Dickerson B, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrell J, Fishman A, Fong J, Foroud T, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman JS, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung R, Huey E, Irwin D, Jones D, Jones L, Kantarci K, Karydas A, Kaufer D, Kerwin D, Kraft R, Kramer J, Kukull W, Litvan I, Lucente D, Lungu C, Mackenzie I, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez MF, Miller B, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin K, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw L, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Wang P, Weintraub S, Wong B, Wszolek Z. Alzheimers Dement; 2020 Jan 26; 16(1):106-117. PubMed ID: 31914218 [Abstract] [Full Text] [Related]
17. Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan. Taomoto D, Sato S, Kanemoto H, Suzuki M, Hirakawa N, Takasaki A, Akimoto M, Satake Y, Koizumi F, Yoshiyama K, Takahashi R, Shigenobu K, Hashimoto M, Miyagawa T, Boeve B, Knopman D, Mori E, Ikeda M. Psychogeriatrics; 2024 Mar 26; 24(2):281-294. PubMed ID: 38152057 [Abstract] [Full Text] [Related]
18. Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, Heuer HW, Knopman D, Kornak J, Boxer A, Rosen H, Boeve B, ARTFL/LEFFTDS Consortium. Alzheimers Dement; 2020 Jan 26; 16(1):79-90. PubMed ID: 31477517 [Abstract] [Full Text] [Related]
19. Latent profile analysis in frontotemporal lobar degeneration and related disorders: clinical presentation and SPECT functional correlates. Borroni B, Grassi M, Agosti C, Paghera B, Alberici A, Di Luca M, Perani D, Padovani A. BMC Neurol; 2007 May 16; 7():9. PubMed ID: 17506892 [Abstract] [Full Text] [Related]
20. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Kapsalaki E, Hadjigeorgiou G, Georgoulias P. Nucl Med Commun; 2012 Dec 16; 33(12):1267-76. PubMed ID: 23018627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]